Dec 13 (Reuters) - Moderna Inc (MRNA.O) said on Monday it had agreed to build a vaccine manufacturing facility in Australia that could make up to 100 million vaccines a year. The facility is also intended to be activated on an urgent basis to support Australia with direct access to rapid pandemic response capabilities, Moderna said in a statement.